Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BAZAN, Viviana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.184
EU - Europa 13.466
AS - Asia 10.376
SA - Sud America 1.608
AF - Africa 301
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 16
Totale 50.004
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.686
SG - Singapore 3.916
RU - Federazione Russa 3.377
CN - Cina 2.645
IT - Italia 2.499
DE - Germania 1.896
FI - Finlandia 1.799
BR - Brasile 1.296
HK - Hong Kong 1.036
VN - Vietnam 898
UA - Ucraina 733
GB - Regno Unito 640
PL - Polonia 586
FR - Francia 486
IE - Irlanda 389
JP - Giappone 368
SE - Svezia 322
IN - India 261
KR - Corea 243
CA - Canada 242
BD - Bangladesh 219
NL - Olanda 151
IQ - Iraq 125
BE - Belgio 124
TR - Turchia 123
MX - Messico 113
RO - Romania 111
AR - Argentina 103
AT - Austria 90
ES - Italia 76
ZA - Sudafrica 69
IR - Iran 66
PK - Pakistan 62
AU - Australia 48
CI - Costa d'Avorio 48
ID - Indonesia 45
MA - Marocco 45
EC - Ecuador 43
VE - Venezuela 42
UZ - Uzbekistan 39
MY - Malesia 38
PH - Filippine 35
JM - Giamaica 30
CL - Cile 29
CZ - Repubblica Ceca 29
TN - Tunisia 29
KE - Kenya 28
CO - Colombia 27
AE - Emirati Arabi Uniti 26
EG - Egitto 25
CH - Svizzera 24
NP - Nepal 23
SA - Arabia Saudita 23
CR - Costa Rica 22
LB - Libano 21
LT - Lituania 21
PY - Paraguay 21
AZ - Azerbaigian 18
IL - Israele 18
KZ - Kazakistan 18
UY - Uruguay 18
DZ - Algeria 17
TW - Taiwan 17
HN - Honduras 16
PT - Portogallo 16
PE - Perù 15
TT - Trinidad e Tobago 15
BG - Bulgaria 13
DO - Repubblica Dominicana 13
GR - Grecia 13
JO - Giordania 13
BO - Bolivia 11
EU - Europa 11
OM - Oman 11
PA - Panama 11
TH - Thailandia 11
AL - Albania 9
DK - Danimarca 9
KG - Kirghizistan 9
GE - Georgia 8
HU - Ungheria 7
MD - Moldavia 7
NI - Nicaragua 7
BY - Bielorussia 6
MM - Myanmar 6
PS - Palestinian Territory 6
UG - Uganda 6
EE - Estonia 5
LV - Lettonia 5
NG - Nigeria 5
RS - Serbia 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
AM - Armenia 4
CY - Cipro 4
ET - Etiopia 4
GA - Gabon 4
GT - Guatemala 4
NO - Norvegia 4
PR - Porto Rico 4
Totale 49.924
Salva come PNG Salva come JPEG
Città #
Ashburn 3.111
Singapore 2.482
Fairfield 2.430
Chandler 1.375
Woodbridge 1.348
San Jose 1.345
Houston 1.138
Wilmington 1.097
Ann Arbor 1.035
Hong Kong 990
Seattle 969
Cambridge 789
Moscow 633
Palermo 624
Zgierz 489
Beijing 411
Council Bluffs 397
Los Angeles 391
Santa Clara 389
New York 383
Dublin 378
Jacksonville 376
The Dalles 369
Tokyo 345
Dallas 344
Helsinki 339
Medford 332
Ho Chi Minh City 295
Frankfurt am Main 278
Des Moines 258
Nanjing 252
Lauterbourg 235
Hefei 218
Hanoi 213
Princeton 213
Altamura 205
Boardman 202
Rome 185
Lawrence 174
San Diego 166
Munich 155
Chicago 148
São Paulo 143
Buffalo 127
Brussels 123
Dearborn 121
Milan 116
Tulsa 111
London 108
Phoenix 108
Ludwigshafen am Rhein 104
Orem 100
Jinan 83
Seoul 83
Shenyang 80
Warsaw 76
Atlanta 74
Nuremberg 72
Seongnam 70
Tianjin 68
Nanchang 65
Brooklyn 61
Kitzingen 61
Venice 61
Hebei 60
Guangzhou 59
Changsha 58
Bremen 55
Kumar 55
Montreal 55
Columbus 54
Denver 53
Amsterdam 51
Chennai 50
Abidjan 48
Poplar 46
Toronto 46
Jiaxing 44
Johannesburg 44
Stockholm 43
Baghdad 40
Da Nang 39
Rio de Janeiro 39
Tehran 38
Boston 37
Ningbo 36
Falls Church 35
Izmir 34
Saint Petersburg 34
San Mateo 34
Verona 34
Haiphong 33
Hangzhou 32
Panama City 32
Shanghai 32
San Paolo di Civitate 31
Auburn Hills 30
Lappeenranta 29
Mumbai 29
Zhengzhou 29
Totale 31.019
Salva come PNG Salva come JPEG
Nome #
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 416
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment 377
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. 365
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 354
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 347
EGFR inhibition in NSCLC: New findings…. and opened questions? 342
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 341
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 327
Dietary restriction: could it be considered as speed bump on tumor progression road? 326
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 326
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 325
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 325
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 320
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 319
Male breast cancer. 316
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 315
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 311
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 311
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 305
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 304
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 304
Anti-endothelin drugs in solid tumors 301
Founder mutations in BRCA1 and BRCA2 genes 299
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 294
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 293
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 293
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 290
Breast cancer genome-wide association studies: there is strength in numbers 289
A headlight on liquid biopsies: a challenging tool for breast cancer management 288
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 283
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 282
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 282
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 280
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 279
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 276
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients 275
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. 273
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 272
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 272
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 272
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. 272
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 269
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 267
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 267
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 267
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 266
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 264
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 263
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 262
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 262
Apoptosis: a relevant tool for anticancer therapy. 261
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 261
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 259
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer. 258
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 258
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 258
Nintedanib in NSCLC: Evidence to date and place in therapy 258
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations 257
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 256
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. 255
Ductal lavage: a way of carefully tracing the breast-secreting duct 255
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 254
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 254
Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family. 253
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. 252
The role of Aurora-A inhibitors in cancer therapy. 252
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 250
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer 249
Monoclonal antibodies in gastrointestinal cancers 248
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 248
Laser Pressure Catapulting (LPC): Optimization LPC-System and Genotyping of Colorectal Carcinomas 247
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 246
A missense mutation associated to early onset breast cancer in a sicilian woman. 244
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. 243
VUS variants in BRCA genes of hereditary breast/ovarian cancer 242
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 241
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma 240
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. 240
miR-20b Modulates VEGF Expression by Targeting HIF-1a and STAT3 in MCF-7 Breast Cancer Cells 239
TP53, Ki-Ras and P16INK4A gene molecular analysis in salivary gland tumors. 239
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability. 238
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors 237
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 237
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 237
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) 236
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 236
P16 ink4A, p53 alterations and S phase fraction are predictive of clinical outcome in laryngeal squamous cell carcinoma. 235
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. 234
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 234
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 233
A study of a new germline mutation in BRCA1 gene in two Sicilian families: a founder mutation? 232
Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy 231
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) 230
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 230
TP53 mutations and microsatellite instability are prognostic factors in gastric cancer? 230
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 229
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 228
Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells. 224
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 224
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 222
Totale 27.182
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.094 215 678 84 126 157 121 200 144 287 372 257 453
2022/20233.910 426 749 86 468 429 583 216 283 410 30 171 59
2023/20242.018 84 241 139 157 127 405 230 241 21 71 23 279
2024/20255.922 103 356 383 434 261 294 622 559 357 733 753 1.067
2025/202619.491 1.645 625 1.222 1.575 1.902 2.886 2.541 1.947 1.399 2.369 646 734
2026/2027559 559 0 0 0 0 0 0 0 0 0 0 0
Totale 51.228